Follow
Juan de la Haba-Rodriguez
Juan de la Haba-Rodriguez
Universidad de Cordoba Hospital Universitario Reina Sofia, IMIBIC, GEICAM
Verified email at uco.com
Title
Cited by
Cited by
Year
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre …
L Gianni, T Pienkowski, YH Im, LM Tseng, MC Liu, A Lluch, ...
The lancet oncology 17 (6), 791-800, 2016
8672016
Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study
E Alba, L Calvo, J Albanell, JR De la Haba, AA Lanza, JI Chacon, ...
Annals of oncology 23 (12), 3069-3074, 2012
2262012
First-line trastuzumab plus an aromatase inhibitor, with or without pertuzumab, in human epidermal growth factor receptor 2–positive and hormone receptor–positive metastatic or …
M Rimawi, JM Ferrero, J de la Haba-Rodriguez, C Poole, S De Placido, ...
Journal of Clinical Oncology 36 (28), 2826-2835, 2018
2012018
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy
A Santonja, A Sánchez-Muñoz, A Lluch, MR Chica-Parrado, J Albanell, ...
Oncotarget 9 (41), 26406, 2018
1762018
Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study
M Martín, S Loibl, G von Minckwitz, S Morales, N Martinez, A Guerrero, ...
Journal of Clinical Oncology 33 (9), 1045-1052, 2015
1622015
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
CE Geyer Jr, JE Garber, RD Gelber, G Yothers, M Taboada, L Ross, ...
Annals of oncology 33 (12), 1250-1268, 2022
1552022
CoCl2, a Mimic of Hypoxia, Induces Formation of Polyploid Giant Cells with Stem Characteristics in Colon Cancer
LM Lopez-Sánchez, C Jimenez, A Valverde, V Hernandez, J Penarando, ...
PloS one 9 (6), e99143, 2014
1452014
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial
G Bianchini, L Pusztai, T Pienkowski, YH Im, GV Bianchi, LM Tseng, ...
Annals of Oncology 26 (12), 2429-2436, 2015
1342015
Nitric oxide and cancer: the emerging role of S-nitrosylation
E Aranda, C Lopez-Pedrera, J R De La Haba-Rodriguez, ...
Current molecular medicine 12 (1), 50-67, 2012
1172012
Trastuzumab deruxtecan in patients with central nervous system involvement from HER2-positive breast cancer: the DEBBRAH trial
JM Pérez-García, M Vaz Batista, P Cortez, M Ruiz-Borrego, JM Cejalvo, ...
Neuro-oncology 25 (1), 157-166, 2023
1122023
Phase III trial of adjuvant capecitabine after standard neo-/adjuvant chemotherapy in patients with early triple-negative breast cancer (GEICAM/2003-11_CIBOMA/2004-01)
A Lluch, CH Barrios, L Torrecillas, M Ruiz-Borrego, J Bines, J Segalla, ...
Journal of clinical oncology 38 (3), 203, 2020
1112020
Patterns in the size structure of the phytoplankton community in the deep fluorescence maximum of the Alboran Sea (southwestern Mediterranean)
J Rodrıguez, JM Blanco, F Jiménez-Gómez, F Echevarrıa, J Gil, ...
Deep Sea Research Part I: Oceanographic Research Papers 45 (10), 1577-1593, 1998
1081998
Anxiety, depression, and asthma control: changes after standardized treatment
J Sastre, A Crespo, A Fernandez-Sanchez, M Rial, V Plaza, FC González, ...
The Journal of Allergy and Clinical Immunology: In Practice 6 (6), 1953-1959, 2018
1012018
Epirubicin–cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive …
C Pico, M Martin, C Jara, A Barnadas, A Pelegri, A Balil, C Camps, A Frau, ...
Annals of Oncology 15 (1), 79-87, 2004
962004
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant …
M Martin, C Zielinski, M Ruiz-Borrego, E Carrasco, N Turner, EM Ciruelos, ...
Annals of oncology 32 (4), 488-499, 2021
922021
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial
E Alba, J Albanell, J de la Haba, A Barnadas, L Calvo, P Sánchez-Rovira, ...
British journal of cancer 110 (5), 1139-1147, 2014
892014
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and …
L Artigas, M Coma, P Matos-Filipe, J Aguirre-Plans, J Farrés, R Valls, ...
PLoS One 15 (10), e0240149, 2020
682020
Epirubicin plus cyclophosphamide followed by docetaxel versus epirubicin plus docetaxel followed by capecitabine as adjuvant therapy for node-positive early breast cancer …
P Sanofi, A Also
J Clin Oncol 33, 3788, 2015
672015
Effect of primary tumor side on survival outcomes in untreated patients with metastatic colorectal cancer when selective internal radiation therapy is added to chemotherapy …
P Gibbs, V Heinemann, NK Sharma, J Taieb, J Ricke, M Peeters, ...
Clinical colorectal cancer 17 (4), e617-e629, 2018
662018
Compositional analysis on the reverted austenite and tempered martensite in a Ti-stabilized supermartensitic stainless steel: Segregation, partitioning and carbide precipitation
JD Escobar, JD Poplawsky, GA Faria, J Rodriguez, JP Oliveira, ...
Materials & Design 140, 95-105, 2018
652018
The system can't perform the operation now. Try again later.
Articles 1–20